"
Uiuce bus model
From 2013.igem.org
Ashleysmoy (Talk | contribs) (Undo revision 343841 by Ashleysmoy (talk)) |
Ashleysmoy (Talk | contribs) (Undo revision 343839 by Ashleysmoy (talk)) |
||
| Line 375: | Line 375: | ||
</div> | </div> | ||
<!--the slidershow begin--> | <!--the slidershow begin--> | ||
| + | <div class="banner"> | ||
| + | <ul> | ||
| + | <li style="background-image: url('https://static.igem.org/mediawiki/2013/e/e8/Smiling_fox.jpg');"> | ||
| + | <div class="inner"> | ||
| + | |||
| + | |||
| + | |||
| + | </div> | ||
| + | </li> | ||
| + | |||
| + | </ul> | ||
| + | </div> | ||
<!--the slidershow end--> | <!--the slidershow end--> | ||
| - | |||
| - | |||
Revision as of 06:54, 28 October 2013
Business Model
Customer Problem
The cloning process consists of several individual steps, each with its own equipment and machinery. It is complex, yet still requires a remarkable amount of human intervention. This results in errors, inconsistencies, and an overall delay in meeting significant synthetic biology milestones. Our team seeks to minimize this “human intervention” element by designing, prototyping, and commercializing an automated cloning system.
Our Solution
Our flagship product, ModuLab, is an automated system designed to optimize cloning, the underlying process of synthetic biology. The ultimate goals of ModuLab are to minimize error, maximize efficiency and provide synthetic biologists with feedback on every stage of the cloning process.
Competitive Analysis
Comp an text
